LATOYA CLARK: Open Payments
NPI 1346566700 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 24 payments from 11 companies in 2025. Trend: 2023 $313 · 2024 $456 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company | 3 | $110 |
| Sumitomo Pharma America, Inc. | 6 | $93 |
| Astellas Pharma US Inc | 4 | $87 |
| SHIELD THERAPEUTICS INC | 3 | $65 |
| Organon LLC | 2 | $47 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| MILLICENT US INC | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: MYFEMBREE, Veozah, ACCRUFER, NEXPLANON, JOURNAVX, APTIMA, Ozempic, FEMLYV.
Industry payments across AL — which companies pay providers there.
